abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity.

Journal: Drug metabolism and personalized therapy

Publication date: 2022

Journal: Drug metabolism and personalized therapy

Publication Year: 2022

Authors & Co-authors:  Akanji Murtala A MA Elijah Oyinloye O OO Oyedolapo Alabi A AA Aderonke Aderionla A AA Opeoluwa Ogunjimi L OL Omoloye Adesina A AA Oladoja Farouk A FA Olatundun Shonde O SO Edatomolaosi Osipitan L OL